Press Releases :: XORTX Therapeutics Inc. (XRTX)

Jun 13, 2022 8:54am EDT

XORTX to Present at BIO International Convention 2022

Jun 08, 2022 7:00am EDT

XORTX to Present at LD Micro Invitational 2022

Jun 06, 2022 7:00am EDT

XORTX Welcomes New Member to the Board of Directors and Appoints Chair

May 25, 2022 8:00am EDT

XORTX to Present at H. C. Wainwright Global Investment Conference 2022

May 05, 2022 7:00am EDT

XORTX Opens an IND for XRx-008 Program for Autosomal Dominant Polycystic Kidney Disease

May 03, 2022 7:00am EDT

XORTX Initiates Dosing of Human Subjects in the XRX-OXY-101 Clinical Trial

Apr 20, 2022 7:00am EDT

XORTX Receives Small and Medium Enterprise Status for the European Union

Apr 12, 2022 7:00am EDT

XORTX Receives No Objection Letter from Health Canada

Apr 07, 2022 7:00am EDT

XORTX Announces Grant of US Patent

Mar 31, 2022 7:00am EDT

XORTX Files IND with US FDA

rss_feed News RSS